Dysport

What Dysport does

Dysport is a prescription pharmaceutical product (abobotulinumtoxinA), a botulinum toxin type A injection marketed by Ipsen Biopharmaceuticals Inc., the US commercial subsidiary of France-based Ipsen Group. It is FDA-approved for treating increased muscle stiffness in patients 2 years of age and older with upper or lower limb spasticity (adult and pediatric), and for cervical dystonia in adults. The product is manufactured by Ipsen Biopharm Limited in Wrexham, UK, and distributed in the US through seven authorized specialty distributors (ASD Healthcare, Besse Medical, Cardinal Health, CuraScript SD, McKesson Specialty Health, McKesson Medical-Surgical, and Metro Medical) plus a direct ordering platform (Dysport DIRECT). The drug is administered as an intramuscular injection by trained specialists, with treatment effects lasting 12-16 weeks or longer depending on indication.

Dysport's core technology is the abobotulinumtoxinA formulation, available in 300-unit and 500-unit single-use vials with specific reconstitution and dilution protocols for each indication. The product's potency units are non-interchangeable with other botulinum toxin products (Botox, Xeomin, Myobloc), and dosing ranges vary by indication (e.g., 500-1000 Units for adult upper limb spasticity, 10-15 Units/kg for pediatric lower limb spasticity). The product has received five FDA approvals over a decade (2009-2019), progressively expanding from cervical dystonia into full adult and pediatric upper and lower limb spasticity coverage.

Dysport generates revenue through prescription drug sales via three reimbursement pathways: specialty pharmacy benefit, medical benefit buy-and-bill, and direct provider purchase. Ipsen supports commercial operations through the IPSEN CARES patient access program (copay assistance as low as $0 for eligible commercially insured patients), a nationwide Injector Locator tool, and healthcare professional education programs including injection training labs and conference presence. The brand targets neurologists, physiatrists, pediatric neurologists, and PM&R specialists, and partners with patient advocacy organizations across stroke, brain injury, dystonia, and cerebral palsy communities.

Name

Dysport

Legal name

Dysport (abobotulinumtoxinA)

Website

https://dysport.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

1–10 employees

Short description

Dysport is a prescription botulinum toxin type A injection (abobotulinumtoxinA) marketed by Ipsen Biopharmaceuticals Inc. in the US, FDA-approved for cervical dystonia in adults and spasticity in patients 2 years and older, administered by trained specialists and distributed through specialty pharmacies and authorized distributors.

Ownership category

akta.pro rank

Product category

Botulinum Toxin Therapeutics (Neurology / Specialty Pharmaceuticals)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Movement Disorders (Parkinson’s, Tremor, Dystonia) (HLAKAIAC)

Keywords

• Botulinum toxin pharmaceutical
• Spasticity treatment drug
• Cervical dystonia therapy
• Neuromuscular injection medication
• Movement disorder biologic

Headquarters

HQ city

Oxford

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Operations, Personnel

Revenue model

1. Prescription Drug Sales: Dysport is sold as a prescription pharmaceutical through multiple channels: directly via Dysport DIRECT, through authorized specialty distributors (ASD Healthcare, Besse Medical, Cardinal Health, CuraScript SD, McKesson), and via specialty pharmacy benefit. Healthcare providers purchase the product and administer injections to patients, with reimbursement through medical benefit or pharmacy benefit.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Dysport (abobotulinumtoxinA) is a prescription intramuscular injection of botulinum toxin type A, offered in 300-unit and 500-unit vials. It is FDA-approved for the treatment of cervical dystonia in adults and for upper and lower limb spasticity in adults and pediatric patients aged 2 years and older, and is administered by trained healthcare specialists such as neurologists, physiatrists, and movement-disorder physicians.

Product overview

Dysport is a single pharmaceutical product (abobotulinumtoxinA), a prescription botulinum toxin type A injection. It is FDA-approved for treating increased muscle stiffness in patients 2 years and older with spasticity (both upper and lower limb, pediatric and adult) and cervical dystonia in adults. The product is available in two vial sizes (300-Unit and 500-Unit) and is administered by trained specialists. Supporting offerings include the IPSEN CARES patient support program, Dysport Copay Assistance Program, Dysport DIRECT ordering platform, and an Injector Locator tool to help patients find trained healthcare providers.

Differentiator

Problem solved

Functional benefit

Brands

• Dysport: Botulinum toxin type A injection for treatment of spasticity and cervical dystonia
• IPSEN CARES

Products and services

• Dysport (abobotulinumtoxinA) for Injection Prescription intramuscular injection of botulinum toxin type A (abobotulinumtoxinA) indicated for the treatment of cervical dystonia in adults, supplied in 300-unit and 500-unit vials for reconstitution by trained healthcare specialists.
• Dysport (abobotulinumtoxinA) — Adult & Pediatric Spasticity Indication Botulinum toxin type A injection indicated for the treatment of upper and lower limb spasticity in adults and pediatric patients aged 2 years and older, administered intramuscularly by trained specialists.
• IPSEN CARES Patient Access Program Patient support program providing benefit verification, prior authorization assistance, financial assistance, and product ordering support for patients prescribed Dysport and other Ipsen therapies.
• Dysport DIRECT Ordering Platform Direct online ordering channel through which healthcare providers purchase Dysport units directly from Ipsen Biopharmaceuticals.
• Dysport Injector Locator Online tool that helps patients and caregivers locate trained Dysport injectors near them.
• Dysport Copay Assistance Program Financial assistance program that reduces out-of-pocket cost to $0 for eligible commercially insured patients prescribed Dysport.

Quantifiable outcome

• Approximately 3 out of 4 adults with upper limb spasticity had response to treatment at week 4 (reduction in stiffness)
• +4 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

13 partnerships are on record, tiered core and minor.

• ASD HealthcarecoreChannel Partner/ Reseller/ DistributorAuthorized specialty distributor for Dysport. Healthcare providers can purchase Dysport through ASD Healthcare. Phone: 1-800-746-6273.
• Besse MedicalcoreChannel Partner/ Reseller/ DistributorAuthorized specialty distributor for Dysport. Healthcare providers can purchase Dysport through Besse Medical. Phone: 1-800-543-2111.
• Cardinal Health Specialty PharmacycoreChannel Partner/ Reseller/ DistributorAuthorized specialty distributor for Dysport. Healthcare providers can purchase Dysport through Cardinal Health Specialty Pharmacy. Phone: 1-866-926-3161.
• CuraScript SDcoreChannel Partner/ Reseller/ DistributorAuthorized specialty distributor for Dysport. Healthcare providers can purchase Dysport through CuraScript SD. Phone: 1-877-599-7748.
• McKesson Specialty HealthcoreChannel Partner/ Reseller/ DistributorAuthorized specialty distributor for Dysport. Healthcare providers can purchase Dysport through McKesson Specialty Health. Phone: 1-800-482-6700.
• McKesson Medical-SurgicalcoreChannel Partner/ Reseller/ DistributorAuthorized specialty distributor for Dysport. Healthcare providers can purchase Dysport through McKesson Medical-Surgical. Phone: 1-800-422-0280.
• Metro MedicalcoreChannel Partner/ Reseller/ DistributorAuthorized specialty distributor for Dysport. Healthcare providers can purchase Dysport through Metro Medical. Phone: 1-800-768-2002.
• Alliance for Patient AccessminorGTM or Marketing PartnerPatient advocacy organization providing information and support for patients. Contact: 1-202-499-4114.
• American Stroke AssociationminorGTM or Marketing PartnerPatient advocacy organization for stroke survivors and those with spasticity. Contact: 1-888-4-STROKE.
• Brain Injury Association of AmericaminorGTM or Marketing PartnerPatient advocacy organization providing support for brain injury survivors. Contact: 1-800-444-6443.
• Dystonia Medical Research FoundationminorGTM or Marketing PartnerPatient advocacy organization for cervical dystonia. Contact: 1-800-377-3978.
• National Spasmodic Torticollis AssociationminorGTM or Marketing PartnerPatient advocacy organization for spasmodic torticollis/cervical dystonia. Contact: 1-657-554-0661.
• Spasmodic Torticollis Info CenterminorGTM or Marketing PartnerPatient advocacy organization providing information on spasmodic torticollis. Contact: 1-888-445-4588.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Teva Pharmaceutical Industries: Large specialty pharma with neurology and movement disorder offerings, including in the spasticity/cervical dystonia prescribing environment. Overlaps in distribution channels and payer contracts but is not a toxin-direct competitor.
• Pfizer: Major pharma with CNS and movement disorder exposures (post Biohaven). Operates at scale in the same specialty prescriber and payer ecosystem as Dysport, though its portfolio does not include a toxin.
• Ipsen Group: Parent company and manufacturer of Dysport via Ipsen Biopharm Limited (UK); operates a broader specialty care portfolio across neurology, oncology, and rare disease. Dysport is one therapeutic franchise within Ipsen's US footprint.
• Novartis: Global pharma with neurology and rare disease franchises relevant to movement disorders and spasticity. Shares specialty distribution and provider access dynamics with Dysport without directly competing in toxins.
• H. Lundbeck: Global neurology specialty pharma with strong presence in movement disorders and adjacent conditions. Targets the same specialist physician channel (neurologists, physiatrists) as Dysport though without a botulinum toxin asset.
• Supernus Pharmaceuticals: Specialty CNS-focused pharmaceutical company with neurology and movement disorder products. Competes for the same physician and payer relationships even though its portfolio is non-toxin based.

Direct peers

• Galderma: Listed in the Dysport contact database as the 'Galderma Special Services' channel for injectables (1-800-221-1749). Operates in the aesthetics/neurology botulinum toxin space, overlapping in physician accounts and patient access programs.
• Allergan Aesthetics / AbbVie (Botox): Sells Botox (onabotulinumtoxinA), the dominant therapeutic and aesthetic botulinum toxin. Direct head-to-head competitor across all of Dysport's FDA-approved indications including cervical dystonia and adult/pediatric spasticity.
• Merz Pharmaceuticals (Xeomin): Sells Xeomin (incobotulinumtoxinA), a competing botulinum toxin type A approved for cervical dystonia, spasticity, and other indications. Same customer base (neurologists, physiatrists) with overlapping distribution and reimbursement dynamics.
• Solstice Neurosciences / US WorldMeds (Myobloc): Sells Myobloc (rimabotulinumtoxinB), a botulinum toxin type B used primarily for cervical dystonia. Competes in the same specialty neurology channel and serves overlapping prescriber specialties.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/DysportUSA
• LinkedInlinkedin.com/company/dysport-abobotulinumtoxina-for-us-hcps

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dysport